Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-025832

President and COO sold 11,280 shares at $222.07 ($2,504,939)

  • President and COO acquired 18,032 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Douglas Robert Andrew President and COO 2022-11-15 Option exercise +1,144 $58.24 $66,627 34,578 D
Douglas Robert Andrew President and COO 2022-11-15 Option exercise +16,888 $58.24 $983,557 51,466 D
Douglas Robert Andrew President and COO 2022-11-15 Sale −11,280 $222.07 $2,504,939 40,186 D
Derivatives
Douglas Robert Andrew President and COO 2022-11-15 Option exercise · ResMed Common Stock Options −1,144 16,888 D
Douglas Robert Andrew President and COO 2022-11-15 Option exercise · ResMed Common Stock Options −16,888 0 D
Open-market sales · 11,280 sh · avg $222.07 · $2,504,939
Loading xslF345X03/form4.xml…